ACE and Alzheimer disease: Rivastigmine is a dual inhibitor of Acetylcholinesterase (ACE) andButyrylcholinesterase (BuCE), the enzymes that co-regulate synaptic levels ofacetylcholine in Alzheimer’s disease patients.